This article provides definitions for standard Milestone Types. These milestones define critical checkpoints throughout the study to ensure consistent tracking and reporting.
The following standard Milestone Types are available:
| Milestone Type Label | Milestone Type Name | Milestone Type Definition |
|---|---|---|
| Close Out Monitoring Visit | close_out_monitoring_visit__ctms |
The final visit to the site has been performed to ensure all trial activities are completed, investigational product has been reconciled, and data is finalized. |
| Country Financial Templates Ready | country_financial_templates_ready__v |
The country contract and budget templates have been finalized and are ready for use. |
| Country Packet Ready | country_packet_ready__v |
The country-specific regulatory packet of key study documents is ready for distribution to sites within that country. |
| Country Selected | country_selected__v |
A country has been selected for inclusion in the study. |
| EC/IRB Application | ec_irb_submission__v |
The study was submitted to the EC/IRB for approval to conduct the study and a decision was received. |
| EC/IRB Approval | ec_irb_approval__v |
The EC/IRB has indicated that the study can proceed, having met all ethical and regulatory requirements. |
| EU CTR Country Approval | eu_ctr_country_approval__v |
The clinical trial has been approved under the EU CTR to conduct the study within the given country. |
| EU CTR Part I Application | eu_ctr_part_i_application__v |
Submission of the Part I Application under the EU CTR, including the core study documents and data, and a decision was received. |
| EU CTR Part II Application | eu_ctr_part_ii_application__v |
Submission of the Part II Application under the EU CTR, including the core study documents and data, and a decision was received. |
| Feasibility Survey Completed | feasibility_survey_completed__v |
The site has submitted answers to the feasibility questionnaire and confirmed their capabilities as it relates to conducting the trial. |
| Final Database Lock | final_database_lock__v |
The completion of all data entry and validation processes has occurred, officially locking the study database and starting statistical processing. |
| Final Tables Ready | final_tables_ready__v |
All statistical tables, figures, and listings summarizing study results are complete and ready for the final study report. |
| First Country Site Initiated | first_country_site_initiated__v |
The first site in the country has opened for enrollment of study participants. |
| First Site Initiated | first_site_initiated__v |
The first site in the study has opened for enrollment of study participants. |
| First Subject Consented | first_subject_consented__v |
The first participant in the study has provided informed consent to participate. |
| First Subject In | fsi__ctms |
The first participant in the study has been enrolled. |
| First Subject Out | first_subject_out__v |
The first participant in the study has completed all study activities, including follow-up. |
| First Subject Randomized | first_subject_randomized__v |
The first participant in the study has been randomized for placement in a treatment group. |
| First Subject Screened | first_subject_screened__v |
The first participant has been assessed for eligibility in the study. |
| First Subject Started Follow Up | first_subject_started_follow_up__v |
The first participant has begun their follow-up period in the study. |
| First Subject Started Treatment | first_subject_started_treatment__v |
The first participant has begun their treatment regimen in the study. |
| First Subject Treated | first_subject_treated__v |
The first participant in the study has completed treatment. |
| Health Authority Application | ha_application__v |
The study was first submitted to a health authority for approval to conduct the study under its purview and a decision was received. |
| Health Authority Approval | ha_approval__v |
The health authority has given its first approval for a study to be conducted under its purview. |
| Interim Analysis | interim_analysis__v |
A statistical analysis to evaluate treatment effects and monitor for any significant findings or safety concerns has been performed. |
| Interim Monitoring Visit | interim_monitoring_visit__ctms |
A scheduled visit to the study site has been performed to review progress, verify data accuracy, and ensure protocol compliance. |
| Key Country Docs Complete | key_country_docs_complete__v |
All essential documents required for the initiation of the country have been finalized and approved. |
| Key Results Ready | key_results_ready__v |
Primary study outcomes and critical data analyses are complete and available for reporting. |
| Key Study Docs Complete | key_study_docs_complete__v |
All essential documents required for the initiation of the study have been finalized and approved. |
| Last Subject Consented | last_subject_consented__v |
The last participant in the study has provided informed consent to participate. |
| Last Subject In | lsi__ctms |
The last participant in the study has been enrolled. |
| Last Subject Out | lso__ctms |
The last participant in the study has completed all study activities, including follow-up. |
| Last Subject Randomized | last_subject_randomized__v |
The last participant in the study has been randomized for placement in a treatment group. |
| Last Subject Screened | last_subject_screened__v |
The last participant has been assessed for eligibility in the study. |
| Last Subject Started Follow Up | last_subject_started_follow_up__v |
The last participant has begun their follow-up period in the study. |
| Last Subject Started Treatment | last_subject_started_treatment__v |
The last participant has begun their treatment regimen in the study. |
| Last Subject Treated | last_subject_treated__v |
The last participant in the study has completed treatment. |
| Other Country Application | other_country_application__v |
Relevant study-related information has been submitted to the relevant authorities at the country level and a decision was received. |
| Other Country Approval | other_country_approval__v |
The relevant authorities have given their approval of the related country submission. |
| Other Site Application | other_site_application__v |
Relevant study-related information has been submitted to the relevant authorities at the site level and a decision was received. |
| Other Site Approval | other_site_approval__v |
The relevant authorities have given their approval of the related site submission. |
| Oversight Monitoring Visit | oversight_monitoring_visit__v |
A quality oversight and relationship management activity has been performed by the Sponsor to evaluate CRA performance, strengthen the Sponsor-Site partnership, and verify that trial conduct protects subject safety and the reliability of trial results. |
| Pre Study Monitoring Visit | pre_study_monitoring_visit__ctms |
The visit to the study site to assess its readiness, capabilities, and resources for conducting the study has been performed. |
| Protocol Amendment | protocol_amendment__v |
A formal revision has been performed on the effective protocol that has modified aspects such as the study design, eligibility or procedures, which may require approval by regulatory authorities and ethics committees. |
| Protocol Approval | protocol_approval__v |
Formal endorsement of the study protocol was granted by the relevant committee or body, allowing the study to proceed. |
| Protocol Concept Approved | protocol_concept_approved__v |
Initial approval of the study concept has been received from the relevant stakeholders, allowing the development of a detailed protocol. |
| Site Activated | site_activated__v |
The site was opened for enrollment of study participants. |
| Site Contracts Executed | site_contracts_executed__v |
All financial documents, including budget and contracts, pertaining to participation in the study by the site have been executed. |
| Site EC/IRB Application | site_ec_irb_application__v |
The study was submitted to the IRB/EC for approval to conduct the study at the site level and a decision was received. |
| Site EC/IRB Approval | site_ec_irb_approval__v |
The EC/IRB has indicated that the study can proceed within the given site, having met all ethical and regulatory requirements. |
| Site Essential Docs Completed | site_essential_docs_completed__v |
All required regulatory and study-related documents for a site have been finalized and approved. |
| Site Greenlight | site_greenlight__v |
Approval was granted for the investigational product to be released to a site. |
| Site Initiation Monitoring Visit | siv__ctms |
A visit to the site has been performed to train site staff, confirm all systems and supplies are ready, and verify regulatory compliance prior to participant enrollment. |
| Site Qualified | site_qualified__v |
Confirmation that a study site has met all necessary criteria and requirements to participate in the study. |
| Site Regulatory Packet Sent | site_reg_packet_sent__v |
The complete set of regulatory documents required for a site has been compiled and sent to the site. |
| Site Selected | site_selected__v |
A site was selected for participation in the study indicating that startup and initiating activities can commence. |
| Study Financial Templates Ready | study_financial_templates_ready__v |
The study contract and budget templates have been finalized and are ready for use. |
| Study Report Submitted | study_report_submitted__v |
The final clinical study report summarizing study results and conclusions was submitted to the regulatory authorities. |